Drugs Is The Price Right
McNair’s tale is typical of the sad truths-and damaging publicity-about drug prices, which have become the focus of the first pitched battle in the health-care wars. Critics in Congress have been pounding the industry for years. But with a new administration committed to reform and less receptive to business advocates, the real fight has just begun. Last week featured the First Lady’s meetings with patients, doctors and pharmacists in Boston and the release of a new study by a congressional research unit, the Office of Technology Assessment (OTA)....